Kardiochirurgia i Torakochirurgia Polska

Abstract

1/2025 vol. 22
Review paper

Could TachoSil application in cardiac surgery be potentially dangerous? A review of the literature

  1. Student’s Scientific Society, Department of Cardiac Surgery, Transplantology, Vascular and Endovascular Surgery, School of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
  2. Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland
  3. Department of Cardiac Surgery, Transplantology, Vascular and Endovascular Surgery, School of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
Kardiochirurgia i Torakochirurgia Polska 2025; 22 (1): 53-57
Online publish date: 2025/03/17
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
The application of TachoSil adhesive is becoming increasingly popular in surgical procedures. A special area of surgical medicine is cardiac surgery, where the adhesive makes it possible to provide hemostasis when classic anastomotic methods are insufficient. There are numerous studies available demonstrating the perioperative efficacy of TachoSil, and its ease of use in the human population. However, studies on the inflammation caused by TachoSil are widely limited to animal experiments. There is a lack of studies on human groups on TachoSil-induced inflammation in cardiac surgery. The purpose of our paper is to review the current knowledge on the use of TachoSil in animals and the incidence of inflammation, in order to determine whether there is a need for similar human studies in cardiac surgery. The paper discusses the details of this problem based on recent scientific reports.
Share
without publication fees
without publication fees